The preventive effect of RANKL inhibition in BM was found to be dependent on the direct effect in RANK-mediated expression of cancer cell-derived osteotropic factors [37,38,39] and also to be more effective than BPs in tumors with high RANK expression [43]. The gene discussed is TNFRSF11A; the disease is cancer.